MUFG Americas’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,652
| Closed | -$132K | – | 578 |
|
|
2022
Q3 | $132K | Sell |
2,652
-660
| -20% | -$35.4K | ﹤0.01% | 410 |
|
|
2022
Q2 | $185K | Sell |
3,312
-512
| -13% | -$28.4K | ﹤0.01% | 384 |
|
|
2022
Q1 | $212K | Sell |
3,824
-4,698
| -55% | -$241K | ﹤0.01% | 378 |
|
|
2021
Q4 | $477K | Sell |
8,522
-3,480
| -29% | -$189K | 0.01% | 325 |
|
|
2021
Q3 | $576K | Sell |
12,002
-2,706
| -18% | -$131K | 0.01% | 304 |
|
|
2021
Q2 | $616K | Sell |
14,708
-34,396
| -70% | -$1.33M | 0.01% | 297 |
|
|
2021
Q1 | $1.66M | Sell |
49,104
-7,940
| -14% | -$283K | 0.03% | 250 |
|
|
2020
Q4 | $1.99M | Buy |
57,044
+3,056
| +6% | +$106K | 0.03% | 237 |
|
|
2020
Q3 | $1.87M | Buy |
53,988
+4,062
| +8% | +$135K | 0.05% | 224 |
|
|
2020
Q2 | $1.63M | Buy |
49,926
+4,356
| +10% | +$139K | 0.05% | 229 |
|
|
2020
Q1 | $1.37M | Sell |
45,570
-10,448
| -19% | -$311K | 0.05% | 228 |
|
|
2019
Q4 | $1.62M | Buy |
56,018
+22,702
| +68% | +$629K | 0.04% | 253 |
|
|
2019
Q3 | $861K | Buy |
33,316
+13,406
| +67% | +$339K | 0.02% | 286 |
|
|
2019
Q2 | $508K | Sell |
19,910
-654
| -3% | -$16.2K | 0.01% | 327 |
|
|
2019
Q1 | $538K | Buy |
20,564
+308
| +2% | +$7.57K | 0.02% | 314 |
|
|
2018
Q4 | $467K | Sell |
20,256
-2,950
| -13% | -$65.6K | 0.01% | 315 |
|
|
2018
Q3 | $547K | Buy |
23,206
+20,206
| +674% | +$493K | 0.02% | 313 |
|
|
2018
Q2 | $69K | Hold |
3,000
| – | – | ﹤0.01% | 489 |
|
|
2018
Q1 | $74K | Sell |
3,000
-2,542
| -46% | -$66.7K | ﹤0.01% | 484 |
|
|
2017
Q4 | $149K | Sell |
5,542
-458
| -8% | -$11.6K | ﹤0.01% | 457 |
|
|
2017
Q3 | $144K | Hold |
6,000
| – | – | ﹤0.01% | 460 |
|
|
2017
Q2 | $129K | Buy |
6,000
+3,000
| +100% | +$60.5K | ﹤0.01% | 470 |
|
|
2017
Q1 | $51K | Hold |
3,000
| – | – | ﹤0.01% | 572 |
|
|
2016
Q4 | $54K | Buy |
+3,000
| New | +$54.4K | ﹤0.01% | 562 |
|
|
2016
Q1 | – | Sell |
-200
| Closed | -$6K | – | 1217 |
|
|
2015
Q4 | $6K | Hold |
200
| – | – | ﹤0.01% | 909 |
|
|
2015
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 962 |
|
|
2015
Q2 | $5K | Sell |
200
-200
| -50% | -$5.62K | ﹤0.01% | 974 |
|
|
2015
Q1 | $11K | Sell |
400
-900
| -69% | -$20.7K | ﹤0.01% | 907 |
|
|
2014
Q4 | $28K | Sell |
1,300
-170
| -12% | -$3.8K | ﹤0.01% | 767 |
|
|
2014
Q3 | $35K | Sell |
1,470
-90
| -6% | -$2.07K | ﹤0.01% | 734 |
|
|
2014
Q2 | $36K | Hold |
1,560
| – | – | ﹤0.01% | 743 |
|
|
2014
Q1 | $36K | Buy |
1,560
+1,360
| +680% | +$29K | ﹤0.01% | 727 |
|
|
2013
Q4 | $4K | Buy |
+200
| New | +$3.48K | ﹤0.01% | 995 |
|
|
2013
Q3 | – | Sell |
-4,450
| Closed | -$69K | – | 1363 |
|
|
2013
Q2 | $69K | Buy |
+4,450
| New | +$74.1K | ﹤0.01% | 1099 |
|
Other funds holding NVO
F
MUFG Americas's NVO Position: Q4 2022 in Review
MUFG Americas sold out of Novo Nordisk (NVO) in Q4 2022, closing a stake of 2,652 shares — an estimated $132K sold.
MUFG Americas first reported a position in NVO in Q2 2013 and held it in 34 quarters. The position peaked at $1.99M in Q4 2020. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.
- MUFG Americas reported no remaining Novo Nordisk position as of Q4 2022 after selling out during the quarter.
- MUFG Americas sold 2,652 Novo Nordisk shares in Q4 2022, an estimated $132K.
- MUFG Americas first reported a position in Novo Nordisk in Q2 2013 and held it in 34 quarters.
- MUFG Americas's Novo Nordisk position peaked at $1.99M in Q4 2020.
- 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.
Based on MUFG Americas's 13F filing for Q4 2022.